These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Intraventricular thrombolysis for massive intraventricular hemorrhage due to periventricular arteriovenous malformations: no absolute contraindications as rescue therapy prior to surgical repair or embolization? Jorens PG; Menovsky TM; Voormolen MH; Van Den Brande E; Parizel PM Clin Neurol Neurosurg; 2009 Jul; 111(6):544-50. PubMed ID: 19328624 [TBL] [Abstract][Full Text] [Related]
6. Intraventricular administration of rt-PA in patients with intraventricular hemorrhage. Fountas KN; Kapsalaki EZ; Parish DC; Smith B; Smisson HF; Johnston KW; Robinson JS South Med J; 2005 Aug; 98(8):767-73. PubMed ID: 16144170 [TBL] [Abstract][Full Text] [Related]
7. Cerebral venous congestion as indication for thrombolytic treatment. Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553 [TBL] [Abstract][Full Text] [Related]
8. Retinal arterial occlusion with LIF using rTPA. Hayreh SS Ophthalmology; 1999 Jul; 106(7):1236-9. PubMed ID: 10406599 [No Abstract] [Full Text] [Related]
9. Intraventricular fibrinolysis does not increase perihemorrhagic edema after intracerebral hemorrhage. Volbers B; Wagner I; Willfarth W; Doerfler A; Schwab S; Staykov D Stroke; 2013 Feb; 44(2):362-6. PubMed ID: 23306318 [TBL] [Abstract][Full Text] [Related]
10. Factors influencing early results and complication rates of the thrombolytic treatment of lower limb ischemia with recombinant tissue-type plasminogen activator. Asciutto G; Geier B; Marpe B; Hummel T; Mumme A Chir Ital; 2006; 58(5):597-604. PubMed ID: 17069188 [TBL] [Abstract][Full Text] [Related]
11. Lysis of intraventricular hematoma with tissue plasminogen activator. Case report. Findlay JM; Weir BK; Stollery DE J Neurosurg; 1991 May; 74(5):803-7. PubMed ID: 1901601 [TBL] [Abstract][Full Text] [Related]
12. Thrombolysis for intraventricular hemorrhage after endovascular aneurysmal coiling. Hall B; Parker D; Carhuapoma JR Neurocrit Care; 2005; 3(2):153-6. PubMed ID: 16174886 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain. Kramer AH; Jenne C; Holodinsky JK; Todd S; Roberts DJ; Kubes P; Zygun DA; Hill MD; Leger C; Wong JH Neurocrit Care; 2015 Dec; 23(3):386-93. PubMed ID: 25739904 [TBL] [Abstract][Full Text] [Related]
14. Intraventricular tissue plasminogen activator for intraventricular hemorrhage caused by an arteriovenous malformation. Keefe K; Kebriaei M; Gard A; Patil AA J Clin Neurosci; 2014 Mar; 21(3):526-9. PubMed ID: 24134809 [TBL] [Abstract][Full Text] [Related]
15. Fibrinolytic treatment of intraventricular haemorrhage preceding surgical repair of ruptured aneurysms and arteriovenous malformations. Mayfrank L; Rohde V; Gilsbach JM Br J Neurosurg; 1999 Apr; 13(2):128-31. PubMed ID: 10616579 [TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage. Mayfrank L; Lippitz B; Groth M; Bertalanffy H; Gilsbach JM Acta Neurochir (Wien); 1993; 122(1-2):32-8. PubMed ID: 8333306 [TBL] [Abstract][Full Text] [Related]
17. Acute stroke management in the elderly. Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Combined External Ventricular Drainage with Intraventricular Fibrinolysis for the Treatment of Intraventricular Haemorrhage with Acute Obstructive Hydrocephalus. Luong CQ; Nguyen AD; Nguyen CV; Mai TD; Nguyen TA; Do SN; Dao PV; Pham HTM; Pham DT; Ngo HM; Nguyen QH; Nguyen DT; Tran TH; Le KV; Do NT; Ngo ND; Nguyen VD; Ngo HD; Hoang HB; Vu HV; Vu LT; Ngo BT; Nguyen BX; Khuong DQ; Nguyen DT; Vuong TX; Be TH; Gaberel T; Nguyen LV Cerebrovasc Dis Extra; 2019; 9(2):77-89. PubMed ID: 31408859 [TBL] [Abstract][Full Text] [Related]
19. Intrathecal fibrinolysis using recombinant tissue plasminogen activator (rTPA) for prevention of cerebral vasospasm and delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage. Experimental and clinical data. Seifert V Neurol Res; 1994 Feb; 16(1):54-8. PubMed ID: 7913533 [TBL] [Abstract][Full Text] [Related]
20. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion. Hattenbach LO; Kuhli-Hattenbach C; Scharrer I; Baatz H Am J Ophthalmol; 2008 Nov; 146(5):700-6. PubMed ID: 18718570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]